Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes

被引:0
|
作者
El-Ghazawi, Kareem [1 ]
Eyo, Ukpong B. [2 ,3 ]
Peirce, Shayn M. [1 ]
机构
[1] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA
[2] Univ Virginia, Ctr Brain Immunol, Dept Neurosci, Charlottesville, VA USA
[3] Glia Sch Med, Charlottesville, VA USA
关键词
Alzheimer's disease; blood-brain barrier; microcirculation; pericyte; type; 2; diabetes; AMYLOID-BETA; BARRIER DISRUPTION; SKELETAL-MUSCLE; TRANSGENIC MICE; MOUSE MODELS; CELLS; MICROGLIA; ACTIVATION; RAT; NEURODEGENERATION;
D O I
10.1111/micc.12877
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The brain microvasculature, which delivers oxygen and nutrients and forms a critical barrier protecting the central nervous system via capillaries, is deleteriously affected by both Alzheimer's disease (AD) and type 2 diabetes (T2D). T2D patients have an increased risk of developing AD, suggesting potentially related microvascular pathological mechanisms. Pericytes are an ideal cell type to study for functional links between AD and T2D. These specialized capillary-enwrapping cells regulate capillary density, lumen diameter, and blood flow. Pericytes also maintain endothelial tight junctions to ensure blood-brain barrier integrity, modulation of immune cell extravasation, and clearance of toxins. Changes in these phenomena have been observed in both AD and T2D, implicating "pericyte pathology" as a common feature of AD and T2D. This review examines the mechanisms of AD and T2D from the perspective of the brain microvasculature, highlighting how pericyte pathology contributes to both diseases. Our review identifies voids in understanding how AD and T2D negatively impact the brain microvasculature and suggests future studies to examine the intersections of these diseases.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Diabetes, microvascular pathology and Alzheimer disease
    Raj N. Kalaria
    Nature Reviews Neurology, 2009, 5 : 305 - 306
  • [2] Diabetes, microvascular pathology and Alzheimer disease
    Kalaria, Raj N.
    NATURE REVIEWS NEUROLOGY, 2009, 5 (06) : 305 - 306
  • [3] Cerebral microvascular pathology in aging and Alzheimer's disease
    Farkas, E
    Luiten, PGM
    PROGRESS IN NEUROBIOLOGY, 2001, 64 (06) : 575 - 611
  • [4] Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes
    Carmen Hierro-Bujalance
    Monica Garcia-Alloza
    Neural Regeneration Research, 2024, (06) : 1189 - 1190
  • [5] Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes
    Hierro-Bujalance, Carmen
    Garcia-Alloza, Monica
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1189 - 1190
  • [6] Brain tissue microarrays in dementia research:: White matter microvascular pathology in Alzheimer's disease
    Sjöbeck, M
    Haglund, M
    Persson, A
    Sturesson, K
    Englund, E
    NEUROPATHOLOGY, 2003, 23 (04) : 290 - 295
  • [7] CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology
    Miners, J. S.
    Kehoe, P. G.
    Love, S.
    Zetterberg, H.
    Blennow, K.
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)
  • [8] CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
    J. S. Miners
    P. G. Kehoe
    S. Love
    H. Zetterberg
    K. Blennow
    Alzheimer's Research & Therapy, 11
  • [9] Pericyte dysfunction in Alzheimer's disease
    Miners, S.
    Harris, R.
    Love, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2018, 44 : 12 - 13
  • [10] Brain parenchymal and microvascular amyloid in Alzheimer's disease
    Vinters, HV
    Wang, ZZ
    Secor, DL
    BRAIN PATHOLOGY, 1996, 6 (02) : 179 - 195